Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
BUSINESS / Companies
Dec 12, 2015
Dow, DuPont agree on $130 billion merger
Chemical titans DuPont and Dow Chemical Co. have agreed to combine in an all-stock merger valued at $130 billion in a first step toward breaking up into three businesses, a move that pleased activist investors and could trigger more consolidation.
JAPAN / Science & Health
Dec 3, 2015
Drugmaker Kaketsuken raided over decades of alleged faked records and illegal additives
It comes to light that the contractor of a leaning condominium ordered the use of 14-meter piles, knowing that 18-meter piles were likely needed.
BUSINESS / Companies
Nov 19, 2015
Paris attack prompts name holdout Isis Pharmaceuticals to finally rebrand
The terrorist attacks in Paris may have finally spurred a brand change for Isis Pharmaceuticals Inc., a drugmaker that until now has steadfastly held on to its name even as the militant group rose in prominence in the Middle East.
WORLD / Science & Health
Oct 8, 2015
Scientists call for urgent trials to judge flu drugs for pandemics
Scientists still don't know if two commonly used flu drugs — Roche's Tamiflu and GlaxoSmithKline's Relenza — really work in seasonal or pandemic flu outbreaks and say robust clinical trials are urgently needed to find out.
Japan Times
BUSINESS
Oct 6, 2015
Tentative TPP rewrites trade rules for autos, drugs, produce, rice and IP, but faces legislative OKs
The tentative agreement on trade negotiated by a dozen Pacific Rim nations will slightly pry open Japan's famously closed rice market, protect brand-name drugs from generic competitors for at least five years and lower tariffs on automobiles.
JAPAN / Science & Health
Aug 27, 2015
Japan health ministry approves new hepatitis C drug under insurance scheme
The tablet drug Harvoni is expected to revolutionize the treatment of patients with hepatitis C genotype 1, which accounts for about 70 percent of all hepatitis C patients in Japan.
WORLD / Science & Health
Jun 18, 2015
New drug compound may beat malaria with single $1 dose
Scientists have discovered a new anti-malarial compound that could treat patients with a single $1 dose, including those with strains of the mosquito-borne disease that are resistant to current drugs.
Japan Times
JAPAN / Science & Health
Jun 2, 2015
Some experts doubt shift to generic drugs is best prescription for health care system
In a desperate bid to stem the rise in health care costs, the government is reining in one of its biggest medical outlays: prescription drugs.
EDITORIALS
May 29, 2015
The risks of medical deregulation
A new system by which patients can request drugs and treatments not yet approved in Japan carries significant risks.
Japan Times
BUSINESS / Markets
Apr 3, 2015
Japan bubble alert found in drug stock rally that won't quit
This year's Japanese stock rally has a surprise leader: pharmaceutical companies, which tend to lag behind the market when it gains.
Japan Times
BUSINESS / Companies
Mar 5, 2015
Takeda gains first foreign chief as Weber is appointed CEO
Takeda Pharmaceutical Co. has named Christophe Weber chief executive officer as part of a planned succession that makes the French national one of the few international executives to lead a Japanese company.
Japan Times
MULTIMEDIA
Feb 24, 2015
Ebola drug developed in Japan 'halved mortality rates' in some Guinea patients
A relatively cheap drug from a subsidiary of Fujifilm being tested against Ebola in Guinea has halved mortality rates in some patients.
Japan Times
BUSINESS / Companies
Feb 9, 2015
Growth concerns loom for Daiichi Sankyo on drug warning
Daiichi Sankyo Co. risks losing a slice of revenue to generic-medicine competition next year. Now, the drugmaker's plans to fill the gap have hit a roadblock and investors worry that growth may flounder.
JAPAN / Science & Health
Feb 6, 2015
Japanese Ebola drug works: France
The French National Institute of Health and Medical Research said Thursday that clinical trials of the Japanese influenza drug Avigan Tablet, also known as Favipiravir, are showing encouraging results on Ebola patients in Guinea.
Japan Times
COMMUNITY / Voices / FOREIGN AGENDA
Feb 4, 2015
Multivitamins may help ward off common cold
Vitamin and mineral supplements are big business in Japan, but are they really any use?
BUSINESS
Feb 3, 2015
Novartis Japan unit faces business suspension order
The health ministry will order a business suspension of around 15 days for a Japanese unit of Swiss pharmaceutical maker Novartis AG for not reporting serious side effects of its drugs, sources close to the matter said on Monday.
WORLD / Science & Health / FOCUS
Jan 30, 2015
Safety concerns cloud promise of powerful new cancer drugs
A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells are proving to be immensely effective weapons against tumors, potentially transforming the $100 billion global market for drugs that fight the disease.
WORLD / Science & Health
Nov 27, 2014
First gene therapy drug sets million-euro price record
The Western world's first gene-therapy drug is set to go on sale in Germany with a price of €1.1 million ($1.4 million), a new record for a medicine to treat a rare disease.
WORLD / Science & Health
Nov 21, 2014
AIDS drugs show promise in treating common eye disease of elderly
A class of drugs used for three decades by people infected with the virus that causes AIDS may be effective in treating a leading cause of blindness among the elderly.
Japan Times
JAPAN / Science & Health / FOCUS
Oct 31, 2014
Japanese doctor helped two Aussies win Nobel in medicine
Naomi Uemura, a 63-year-old physician who specializes in digestive organs, is credited with conducting the tenacious clinical research that helped two Australian doctors win the Nobel Prize in medicine in 2005.

Longform

When trying to trace your lineage in Japan, the "koseki" is the most important form of document you'll encounter.
Climbing the branches of a Japanese family tree